Synthesis and characterization of PEG-based drug-responsive biohybrid hydrogels.
Raphael J Gübeli, Martin Ehrbar, Martin Fussenegger, Christian Friedrich, Wilfried Weber
Index: Macromol. Rapid Commun. 33(15) , 1280-5, (2012)
Full Text: HTML
Abstract
Interactive materials being responsive to a biocompatible stimulus represent a promising approach for future therapeutic applications. In this study, we present a novel biohybrid material synthesized from biocompatible components being stimulus-responsive to the pharmaceutically approved small-molecule novobiocin. The hydrogel design is based on the gyrase B (GyrB) protein, which is covalently grafted to multi-arm polyethylene glycol (PEG) using a Michael-type addition reaction. Upon addition of the GyrB-dimerizing substance coumermycin, stable hydrogels form which can be dissolved in a dose-adjustable manner by the antibiotic novobiocin. The switchable properties of this PEG-based hydrogel are favorable for future applications in tissue engineering and as externally controlled drug depot.Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Related Compounds
Related Articles:
2014-01-01
[PLoS ONE 9(8) , e105272, (2014)]
2014-08-05
[Biochemistry 53(30) , 5034-41, (2014)]
2015-05-01
[Pharm. Res. 32(5) , 1634-47, (2015)]
2014-05-30
[Oncotarget 5(10) , 3287-306, (2014)]
2012-03-01
[Lett. Appl. Microbiol. 54(3) , 247-54, (2012)]